Investor Expectations to Drive Momentum within Criteo S.A, Prima BioMed, CoStar Group, DBV Technologies S.A, Hollysys Automation Technologies, and China Biologic Products — Discovering Underlying Factors of Influence
April 13, 2018 07:45 ET | Fundamental Markets
NEW YORK, April 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
Prima BioMed Changes Its Name to Immutep Ltd
November 20, 2017 01:59 ET | Prima BioMed Ltd
SYDNEY, Australia, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the “Company”) has announced a rebranding of the Company from Prima BioMed Ltd to Immutep...
Prima BioMed Ltd: Operational Update
August 18, 2016 05:00 ET | Prima BioMed Ltd
SYDNEY, AUSTRALIA--(Marketwired - Aug 18, 2016) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), has provided an update on the Company's cash position and the recruitment progress in its two active...
Prima BioMed and Neopharm Ltd Enter Into License for CVac in Israel
November 06, 2013 07:00 ET | Prima BioMed
SYDNEY, AUSTRALIA--(Marketwired - Nov 6, 2013) -  Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that it has entered into a...
Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details
June 12, 2012 22:57 ET | Prima BioMed
SYDNEY, AUSTRALIA--(Marketwire - Jun 12, 2012) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) confirms the webcast and dial in details for the shareholder briefing to be held on Friday 15th June...
Nasdaq.jpg.prdesk.globenewswire.jpg
Prima BioMed Ltd to Ring The NASDAQ Stock Market Opening Bell to Celebrate Listing on The NASDAQ Stock Market
April 16, 2012 06:00 ET | Nasdaq, Inc.
ADVISORY, April 16, 2012 (GLOBE NEWSWIRE) -- What: Prima BioMed Ltd, a world leader in cancer immunotherapies, will visit the NASDAQ MarketSite in Times Square to celebrate its listing on The...